The Promise of Artificial Intelligence in Reshaping Anticancer Drug Development
Kostas A. Papavassiliou,
Amalia A. Sofianidi,
Vassiliki A. Gogou,
Athanasios G. Papavassiliou
Affiliations
Kostas A. Papavassiliou
First University Department of Respiratory Medicine, Medical School, ‘Sotiria’ Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece
Amalia A. Sofianidi
Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece
Vassiliki A. Gogou
First University Department of Respiratory Medicine, Medical School, ‘Sotiria’ Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece
Athanasios G. Papavassiliou
Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece
While the concept of artificial intelligence (AI) has deep historical roots, its development as a formal scientific field was initiated in the 1950s by Newell and Simon, who invented a “thinking machine” called the Logic Theorist [...]
